Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Robert Driscoll Maintained (BDTX) at Buy with Increased Target to $16 on, Apr 8th, 2024
Robert Driscoll of Wedbush, Maintained "Black Diamond Therapeutics, Inc." (BDTX) at Buy with Increased Target from $10 to $16 on, Apr 8th, 2024.
Robert has made no other calls on BDTX in the last 4 months.
There is 1 other peer that has a rating on BDTX. Out of the 1 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $12 on, Monday, March 18th, 2024
